Diaceutics Future Growth
Future criteria checks 5/6
Diaceutics is forecast to grow earnings and revenue by 59.5% and 21.6% per annum respectively while EPS is expected to grow by 54.4% per annum.
Key information
59.5%
Earnings growth rate
54.4%
EPS growth rate
| Life Sciences earnings growth | 11.3% |
| Revenue growth rate | 21.6% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 21 Mar 2024 |
Recent future growth updates
Recent updates
Diaceutics PLC's (LON:DXRX) Subdued P/S Might Signal An Opportunity
Jan 31
Industry Analysts Just Made A Notable Upgrade To Their Diaceutics PLC (LON:DXRX) Revenue Forecasts
Jan 28Estimating The Intrinsic Value Of Diaceutics PLC (LON:DXRX)
Jul 24Would Shareholders Who Purchased Diaceutics' (LON:DXRX) Stock Year Be Happy With The Share price Today?
Feb 04
Here's Why We Don't Think Diaceutics's (LON:DXRX) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 31Do Insiders Own Lots Of Shares In Diaceutics PLC (LON:DXRX)?
Nov 27Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 48 | 6 | 5 | 10 | 2 |
| 12/31/2025 | 38 | 1 | 1 | 6 | 5 |
| 12/31/2024 | 30 | -2 | -3 | 3 | 6 |
| 12/31/2023 | 24 | -2 | -4 | 2 | 6 |
| 6/30/2023 | 22 | 0 | -3 | 3 | N/A |
| 3/31/2023 | 21 | 0 | -1 | 4 | N/A |
| 12/31/2022 | 20 | 1 | 0 | 5 | N/A |
| 9/30/2022 | 18 | 0 | N/A | N/A | N/A |
| 6/30/2022 | 16 | 0 | -3 | 3 | N/A |
| 3/31/2022 | 15 | 0 | -4 | 2 | N/A |
| 12/31/2021 | 14 | 1 | -5 | 1 | N/A |
| 9/30/2021 | 14 | 0 | N/A | N/A | N/A |
| 6/30/2021 | 13 | -1 | -6 | 0 | N/A |
| 3/31/2021 | 13 | 0 | -6 | 0 | N/A |
| 12/31/2020 | 13 | 0 | -6 | 0 | N/A |
| 9/30/2020 | 14 | 2 | -5 | 1 | N/A |
| 6/30/2020 | 14 | 3 | -4 | 1 | N/A |
| 3/31/2020 | 14 | 2 | -4 | 0 | N/A |
| 12/31/2019 | 13 | 0 | -4 | -1 | N/A |
| 9/30/2019 | 12 | 0 | -3 | 0 | N/A |
| 6/30/2019 | 11 | 0 | -2 | 0 | N/A |
| 3/31/2019 | 11 | 0 | -2 | -1 | N/A |
| 12/31/2018 | 10 | 1 | -2 | -1 | N/A |
| 12/31/2017 | 7 | 1 | 1 | 2 | N/A |
| 12/31/2016 | 5 | 1 | N/A | 1 | N/A |
| 12/31/2015 | 1 | 0 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DXRX's forecast earnings growth (59.5% per year) is above the savings rate (1.6%).
Earnings vs Market: DXRX's earnings (59.5% per year) are forecast to grow faster than the UK market (12.2% per year).
High Growth Earnings: DXRX's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: DXRX's revenue (21.6% per year) is forecast to grow faster than the UK market (3.3% per year).
High Growth Revenue: DXRX's revenue (21.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DXRX's Return on Equity is forecast to be high in 3 years time